E0302 IR

Eisai Co., Ltd. · Phase 1 active Small molecule

At a glance

Generic name	E0302 IR
Sponsor	Eisai Co., Ltd.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

E0302 IR CI brief — competitive landscape report
E0302 IR updates RSS · CI watch RSS
Eisai Co., Ltd. portfolio CI